IP Library Granted Patent US 12,364,952
Granted Patent B2
US 12,364,952 · App. 17/108,775 · Granted Jul 22, 2025

Tangential flow filter system for the filtration of materials from biologic fluids

Inventors: Emily Rolfes Meyering (St. Louis Park, MN); Gary Seim (Minneapolis, MN); Abhi Vase (Los Altos Hills, CA); Ben Krehbiel (Lake City, MN); Blake Hedstrom (Minneapolis, MN); Aaron McCabe (Edina, MN)
Assignee: MINNETRONIX, INC.
B01D61/58A61M1/88A61M1/884A61M25/00B01D61/145B01D61/147B01D61/149B01D61/32A61M27/006A61M2202/0464A61M2205/3327A61M2205/3334A61M2205/75A61M2206/11A61M2230/005B01D2311/12B01D2311/16B01D2313/12B01D2313/18B01D2315/08B01D2315/10B01D2317/022B01D2317/04B01D2317/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,364,952
App. No.
17/108,775
Granted
Jul 22, 2025
Kind
B2
Abstract

Systems and methods for filtering materials from biologic fluids are discussed. Embodiments may be used to filter cerebrospinal fluid (CSF) from a human or animal subject. The method may include the steps of withdrawing fluid comprising CSF, filtering the volume into permeate and retentate by passing the fluid through a tangential flow filter, and returning the permeate to the subject. During operation of the system, various parameters may be modified, such as flow rate.

Claims (24)

1. A system for filtering materials from cerebrospinal fluid (CSF) of a human or animal subject, the system comprising:

a filtration system, the filtration system including a multi-lumen catheter, a pump, a first filter, a second filter, and a combiner;

a processor coupled to the filtration system;

wherein the multi-lumen catheter is configured to be inserted at least partially into a CSF-containing space of a subject for withdrawing a first volume of a fluid comprising CSF from the CSF-containing space of the subject at a first flow rate through a first lumen formed in the multi-lumen catheter;

wherein the filtration system is configured to operate according to a set of operation parameters;

wherein the first filter includes a tangential flow filter for filtering the first volume of the fluid into a first permeate and a first retentate;

wherein the second filter is configured to filter the first retentate into a second permeate and a second retentate;

wherein the combiner is configured to combine the first permeate with the second permeate to form a combined permeate;

wherein the filtration system includes one or more sensors for measuring the first volume, a volume of the combined permeate, and a difference between the first volume and a volume of the combined permeate;

wherein the multi-lumen catheter is designed to return the combined permeate through a second lumen formed in the multi-lumen catheter to the CSF-containing space of the subject at a second flow rate;

and

wherein the processor is configured to update a parameter of the set of operation parameters when the difference between the first volume and the volume of the combined permeate exceeds a predetermined threshold.

2. The system of claim 1 , wherein the parameter comprises the first flow rate and the second flow rate.

3. The system of claim 2 , wherein updating the parameter of the set of operation parameters comprises equalizing the first flow rate and the second flow rate.

4. The system of claim 1 , wherein the predetermined threshold is a difference between the first volume and the volume of the combined permeate that is predicted to induce a spinal headache.

5. The system of claim 4 , wherein the subject is a human subject and the difference between the first volume and the volume of the combined permeate that is predicted to induce a spinal headache is between about 35 milliliters per hour and 45 milliliters per hour.

6. The system of claim 1 , wherein the parameter of the set of operation parameters comprises a flow rate parameter and updating the parameter of the set of operation parameters causes the first and second flow rate to decrease.

7. The system of claim 1 , wherein the first flow rate is between approximately 0.04 milliliters per minute and approximately 30 milliliters per minute.

8. The system of claim 1 , wherein the filtration system includes a port for adding a therapeutic agent to the combined permeate prior to returning the combined permeate to the CSF-containing space.

9. The system of claim 1 , wherein the filtration system includes a port for adding artificial CSF to the combined permeate prior to returning the combined permeate to the CSF-containing space.

10. The system of claim 1 , further comprising:

a second sensor for measuring is an absolute retentate flow rate;

wherein the filtration system is designed to determine whether passes a second threshold, where the second threshold is a range of acceptable retentate flow rates; and

wherein the filtration system is designed to update a second parameter of the set of operation parameters to cause the absolute retentate flow rate to return to within the range of acceptable retentate flow rates.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2025
From: MINNETRONIX NEURO, INC.
To: PHARAOH NEURO, INC.
Reel/Frame 073429/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2025
From: MINNETRONIX, INC.
To: MINNETRONIX NEURO, INC.
Reel/Frame 071588/0980 →
ASSIGNMENT OF SECURITY INTEREST IN PATENT COLLATERAL RECORDED ON REEL 054795 FRAME 0607 AND SUPPLEMENTAL PATENT SECURITY AGREEMENT RECORDED ON REEL 056240 FRAME 0147 Recorded Mar 13, 2025
From: FIRST HORIZON BANK
To: TEXAS CAPITAL BANK, AS SUCCESSOR AGENT
Reel/Frame 073460/0969 →